Patents for C12P 21 - Preparation of peptides or proteins (112,499)
05/2000
05/31/2000EP1003862A1 Human longevity-assurance protein homologs
05/31/2000EP1003858A1 New human growth regulator protein
05/31/2000EP1003857A2 Secreted proteins and polynucleotides encoding them
05/31/2000EP1003856A1 Apaf-1, the ced-4 human homolog, an activator of caspase-3
05/31/2000EP1003855A2 Secreted proteins and polynucleotides encoding them
05/31/2000EP1003853A1 Methods for protein screening
05/31/2000EP1003851A2 Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy
05/31/2000EP1003842A1 Catalytic monoclonal antibodies for the in vivo transformation of corticosteroid prodrugs
05/31/2000EP1003841A1 Establishment of hhv-8+ lymphoma cell line, virus produced, antibody, diagnostic method and kit for detecting hhv-8 infection
05/31/2000EP1003783A2 Lipoprotein-regulating medicaments
05/31/2000EP1003781A1 Interleukin-18 binding proteins, their preparation and use
05/31/2000EP1003780A1 Human f11 antigen: a cell surface receptor involved in platelet aggregation
05/31/2000EP1003778A1 Isolated osteocalcin fragments
05/31/2000EP1003770A1 Secreted proteins and polynucleotides encoding them
05/31/2000EP1003768A1 Secreted proteins and polynucleotides encoding them
05/31/2000EP1003767A1 Human tumor necrosis factor receptor tr10
05/31/2000EP1003763A1 83 human secreted proteins
05/31/2000EP1003545A1 Heparin-binding growth factor (hbgf) polypeptides
05/31/2000EP1003379A1 Novel phytase
05/31/2000EP1003365A1 Atrial natriuretic factor mutants and ischemic stroke
05/31/2000EP0804559A4 Enzyme for cleavage of the anchor region of surface proteins from gram positive bacteria
05/31/2000EP0791013B1 Methods and compositions for screening for presynaptic calcium channel blockers
05/31/2000EP0584082B1 Domains of extracellular region of human platelet derived growth factor receptor polypeptides
05/31/2000EP0464022B1 Insulinotropic hormone
05/31/2000EP0383779B2 PROCESS FOR THE PRODUCTION OF PROTEIN PRODUCTS IN $i(ASPERGILLUS) AND PROMOTERS FOR USE IN $i(ASPERGILLUS)
05/31/2000CN1255163A Compounds
05/31/2000CN1053012C Hog choera virus vaccine and diagnostic
05/30/2000US6069301 Antibodies which bind to insect gut proteins and their use
05/30/2000US6069241 Amino acid and nucleotide sequences of gene expressed specifically at initial stages in flower-bud growth; for controlling plant flowering
05/30/2000US6069239 Expression system present in compatible host cell which produces a ligand regulated transcription factor; antiinflammatory/antiarthritic/antidiabetic agents; treatment of autoimmune diseases; diagnosis of related diseases
05/30/2000US6069235 Method for carbohydrate engineering of glycoproteins
05/30/2000US6069231 Amino acid sequences of domains found in transcription factors including a mammalian retinoblastoma-interacting zinc finger protein; for fusion proteins useful for regulating transcription of target genes; diagnosis of related diseases
05/30/2000US6069230 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications
05/30/2000US6069127 Human infant formula containing a glycoprotein specific for binding to the human mac-2 (macrophage antigen) lectin; to prevent infections
05/30/2000US6069009 Method for increasing the growth of plant cell cultures
05/30/2000US6069001 Nucleotide sequence; for use in diagnosis of cancer and melanoma; for use in human leukocyte antigen typing for grafts and transplants
05/30/2000US6068995 Method for producing protein
05/30/2000US6068993 Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
05/30/2000US6068992 Production of gonorrheal PI proteins and vaccines
05/30/2000US6068984 Separating hb15 prositive cells from population of unrelated cells by reacting antibody that specifically binds the extracellular, transmembrane or cytoplasmic domain of the glycoprotein, then isolating cells
05/30/2000US6068983 Introducing into cells a dna molecule coding for an fc receptor which is then expressed for increased phagocytic activity; combating infection and/or modulating immune complex disease
05/30/2000US6068842 A polypeptide containing 66 kda protein of borrelia afzelli
05/30/2000US6068841 Antibodies to Fas-L for treatment of hepatitis
05/30/2000US6068840 Recombinant CDR-grafted and chimeric anti-IL-8 antibodies containing CDRs or the variable region from the mouse monoclonal antibody, WS-4
05/30/2000CA2676762A1 Peptides for the detection of hiv-1 group o
05/30/2000CA2223360C Cyclic peptide compounds and their production process
05/30/2000CA2158274C Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
05/30/2000CA2119128C Alleviation of symptoms associated with inflammatory disease states
05/30/2000CA2092953C Enzymatic hydrolysis
05/30/2000CA2044630C Subtilisin mutants
05/30/2000CA2026570C Method for production and purification of hepatitis b vaccine
05/26/2000CA2252967A1 Protein fragments for use in protein targeting
05/25/2000WO2000029850A1 An immunoassay for the determination of transmissible spongiform encephalopathies in bovine
05/25/2000WO2000029849A1 An immunoassay for the determination of transmissible spongiform encephalopathies in mammals
05/25/2000WO2000029584A1 Antibody variants with higher binding affinity compared to parent antibodies
05/25/2000WO2000029583A2 Immunoglobulin superfamily proteins
05/25/2000WO2000029581A1 Human tslp dna and polypeptides
05/25/2000WO2000029580A1 Calcium binding protein
05/25/2000WO2000029577A1 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof
05/25/2000WO2000029572A1 Proteins maguin
05/25/2000WO2000029564A2 Human glycine transporter type 2
05/25/2000WO2000029561A2 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope
05/25/2000WO2000029447A1 Rhamm antagonist antibodies
05/25/2000WO2000029446A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies
05/25/2000WO2000029444A1 Generation of antibodies using polynucleotide vaccination in avian species
05/25/2000WO2000029442A1 Method for producing antibodies acting against a polypeptide that only recognises the coding nucleic acid
05/25/2000WO2000029438A1 Egf-like nucleic acids and polypeptides and uses thereof
05/25/2000WO2000029436A1 Protein amsh and cdna thereof
05/25/2000WO2000029435A1 12 human secreted proteins
05/25/2000WO2000029430A1 Ring finger protein zapop3
05/25/2000WO2000029422A1 31 human secreted proteins
05/25/2000WO2000029017A1 Mycobacterium tuberculosis superoxide dismutase
05/25/2000WO2000029004A1 Small functional units of antibody heavy chain variable regions
05/25/2000WO2000028818A1 7-transmembrane receptor mouse kiaa0001
05/25/2000WO2000019988A8 NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF
05/25/2000WO2000014228A8 Neutral amino acid transporter and gene thereof
05/25/2000WO2000014227A8 Novel protein and dna thereof
05/25/2000WO2000009543A3 Hepatitis c inhibitor tri-peptides
05/25/2000WO2000007545A8 Apoptosis proteins
05/25/2000CA2779042A1 Bioengineered tissue constructs and methods for producing and using them
05/25/2000CA2369119A1 Nucleotide construct with optimised codons for an hiv genetic vaccine based on a primary, early hiv isolate and synthetic envelope
05/25/2000CA2351669A1 Small functional units of antibody heavy chain variable regions
05/25/2000CA2351522A1 Egf-like nucleic acids and polypeptides and uses thereof
05/25/2000CA2350785A1 31 human secreted proteins
05/25/2000CA2350698A1 Human glycine transporter type 2
05/25/2000CA2350603A1 Ring finger protein zapop3
05/25/2000CA2350391A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies
05/25/2000CA2350389A1 Calcium binding protein
05/25/2000CA2350111A1 Generation of antibodies using polynucleotide vaccination in avian species
05/25/2000CA2350078A1 Method for producing antibodies acting against a polypeptide that only recognises the coding nucleic acid
05/25/2000CA2349762A1 Human tslp dna and polypeptides
05/25/2000CA2348824A1 12 human secreted proteins
05/25/2000CA2348479A1 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof
05/25/2000CA2347833A1 Antibody variants with higher binding affinity compared to parent antibodies
05/24/2000EP1002542A1 Method for treating the endotoxic shock in mammals
05/24/2000EP1002132A1 90 human secreted proteins
05/24/2000EP1002112A1 Agent for expressing and detecting a fusion polypeptide with an hpol-epitope and a polypeptide
05/24/2000EP1002111A2 Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells
05/24/2000EP1002110A1 Immune responses against hpv antigens elicited by compositions comprising an hpv antigen and a stress protein or an expression vector capable of expression of these proteins
05/24/2000EP1002107A1 Mass production method of antimicrobial peptide and dna construct and expression system thereof